The disqualification of two-time Tour de France runner-up Nairo Quintana from his sixth place within the 2022 race for misuse of an opioid was confirmed by the Court docket of Arbitration for Sport on Thursday.
CAS mentioned its judges dismissed Quintana’s enchantment and agreed with the Worldwide Biking Union that the case was a medical matter slightly than a doping guidelines violation. He is not going to be banned.
The court docket mentioned the judges dominated “the UCI’s in-competition ban on tramadol was for medical slightly than doping causes and was due to this fact inside the UCI’s energy and jurisdiction.”
Traces of the artificial painkiller tramadol had been present in two dried blood spot samples taken from the Colombian racer 5 days aside in July, the UCI beforehand mentioned.
Quintana’s case is among the many first to depend on the dried blood spot (DBS) methodology of accumulating samples which the World Anti-Doping Company accredited final yr.
Tramadol was banned in 2019 from use at biking races due to potential negative effects. They embody the chance of dependancy, dizziness, drowsiness and lack of consideration.
Quintana completed second within the Tour de France in 2013 and 2015, received each occasions by Chris Froome. He received the 2014 Giro d’Italia.